Stoky
Back to explore
N
NoahListening
A
AshListening
0:00 / 0:00I. Business Overview and Strategic Initiatives
ZBH logo

Zimmer Biomet Achieves 7.2% Sales Growth Amid Strategic Tech Acquisitions

ZBH10-KFiling Date: 2/20/2026
Zimmer Biomet Holdings, Inc.
Description

What this story covers

Zimmer Biomet’s 2025 10-K reveals 7.2% sales growth driven by the Paragon 28 acquisition and ZBEdge robotic integration. Despite a dip in net earnings due to restructuring and inventory charges, strong cash flows support a positive 2026 outlook.

Story snapshot

CompanyZimmer Biomet Holdings, Inc.
TickerZBH
VariantStandard detailed
Duration10:47
Filing type10-K
PeriodAnnual 2025
IndustryHealthcare & Pharmaceuticals
Accession0001193125-26-059853
Sources1

Full Story Script

Content not available for this story.

Primary Sources

sec_filing10-KView on SEC.gov →

Ask Noah

Question the story, source filings, and key financial signals.

Sign in to chat with Noah

Ask questions about revenue, margins, risk factors, filings and more. Noah uses retrieval-augmented analysis over raw financial disclosures.

Sign in